Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Int J Radiat Oncol Biol Phys ; 91(4): 807-16, 2015 Mar 15.
Article in English | MEDLINE | ID: mdl-25752395

ABSTRACT

PURPOSE: We previously screened natural compounds and found that coniferyl aldehyde (CA) was identified as an inducer of HSF1. In this study, we further examined the protective effects of CA against ionizing radiation (IR) in normal cell system. METHODS AND MATERIALS: Western blotting and reverse transcription-polymerase chain reaction tests were performed to evaluate expression of HSF1, HSP27, and HSP70 in response to CA. Cell death and cleavage of PARP and caspase-3 were analyzed to determine the protective effects of CA in the presence of IR or taxol. The protective effects of CA were also evaluated using animal models. RESULTS: CA increased stability of the HSF1 protein by phosphorylation at Ser326, which was accompanied by increased expression of HSP27 and HSP70. HSF1 phosphorylation at Ser326 by CA was mediated by EKR1/2 activation. Cotreatment of CA with IR or taxol in normal cells induced protective effects with phosphorylation- dependent patterns at Ser326 of HSF1. The decrease in bone marrow (BM) cellularity and increase of terminal deoxynucleotidyl transferase dUTP nick end labeling-positive BM cells by IR were also significantly inhibited by CA in mice (30.6% and 56.0%, respectively). A549 lung orthotopic lung tumor model indicated that CA did not affect the IR-mediated reduction of lung tumor nodules, whereas CA protected normal lung tissues from the therapeutic irradiation. CONCLUSIONS: These results suggest that CA may be useful for inducing HSF1 to protect against normal cell damage after IR or chemotherapeutic agents.


Subject(s)
Acrolein/analogs & derivatives , DNA-Binding Proteins/metabolism , HSP27 Heat-Shock Proteins/metabolism , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/pharmacology , Transcription Factors/metabolism , Acrolein/pharmacology , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Bone Marrow Cells/drug effects , Bone Marrow Cells/radiation effects , Cell Line, Tumor , DNA-Binding Proteins/genetics , Female , HSP27 Heat-Shock Proteins/genetics , HSP70 Heat-Shock Proteins , Heat Shock Transcription Factors , Humans , In Situ Nick-End Labeling/methods , Lung Neoplasms/radiotherapy , MAP Kinase Signaling System , Mice , Mice, Inbred BALB C , Mice, Inbred ICR , Mice, Nude , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Paclitaxel/pharmacology , Phosphorylation , RNA, Messenger/metabolism , Radiation Injuries, Experimental/chemically induced , Transcription Factors/genetics , Whole-Body Irradiation/methods
2.
Eur Rev Med Pharmacol Sci ; 18(24): 3889-97, 2014.
Article in English | MEDLINE | ID: mdl-25555880

ABSTRACT

OBJECTIVE: Cyclophosphamide (CTX) can attack tumour cells, but can also damage the other cells and microstructures of an organism at different levels, such as haematopoietic cells, liver cells, peripheral lymphocyte DNA, and genetic materials. Low dose radiation (LDR) can induce general adaptation reaction. In this study, we explore the effects of low dose radiation on hepatic damage and genetic material damage caused by CTX. MATERIALS AND METHODS: Mice were implanted subcutaneously with S180 cells in the left groin (control group excluded). On days 8 and 11, mice of the LDR and LDR+CTX groups were given 75 mGy of whole-body γ-irradiation; whereas mice of the CTX and LDR+CTX groups were injected intraperitoneally with 3.0 mg of CTX. All mice were sacrificed on day 13. DNA damage of the peripheral lymphocytes, alanine aminotransferase (ALT) activity, total protein (TP), albumin (ALB) of the plasma, malonyl-dialdheyde (MDA) content, superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX) activity of the hepatic homogenate, and micronucleus frequency (MNF) of polychromatoerythrocytes in the bone marrow were analysed. RESULTS: The control group had the lowest MDA content and the highest SOD and GSH-PX activity, whereas the CTX group had the highest MDA content and the lowest SOD and GSH-PX activity. Compared with the CTX group, the MDA content decreased significantly (p < 0.01) and the SOD and GSH-PX activity increased significantly (p < 0.05) in the LDR+CTX group. TP and ALB in control group were higher than that of the other groups. Compared with the sham-irradiated group, TP and ALB in the LDR group elevated significantly (p < 0.05). The control group had the lightest DNA damage, whereas the CTX group had the severest. DNA damage in LDR+CTX group was much lighter compared with that of the CTX group (p < 0.05). MNF in the CTX group increased significantly compared with the control and the sham-irradiated groups (p < 0.01). Compared with the CTX group, MNF in LDR+CTX group had a tendency of decline, but without statistical significance (p > 0.05). CONCLUSIONS: Pre-chemotherapeutic LDR can induce the activities of anti-oxidative enzymes and promote the elimination of free radicles to alleviate the damaging effects of oxidative stress to hepatic tissue caused by high-dose CTX. At the same time, LDR has no obvious effect on the ALT activity of plasma, but may have protective effect on the protein synthesis function of the liver. High-dose CTX chemotherapy can cause DNA damage of peripheral lymphocytes; however, LDR before chemotherapy may have certain protective effect on DNA damage. Moreover, CTX has potent mutagenic effect; however, LDR may have no protective effect against the genetic toxicity of CTX chemotherapy.


Subject(s)
Cyclophosphamide/toxicity , DNA Damage , Liver Diseases/etiology , Liver/drug effects , Liver/radiation effects , Radiation Injuries, Experimental/etiology , Alanine Transaminase/blood , Animals , Dose-Response Relationship, Radiation , Liver/metabolism , Liver/pathology , Liver Diseases/genetics , Liver Diseases/metabolism , Lymphocytes/drug effects , Lymphocytes/radiation effects , Male , Malondialdehyde/metabolism , Mice , Oxidative Stress/drug effects , Radiation Injuries, Experimental/chemically induced , Radiation Injuries, Experimental/genetics , Sarcoma/drug therapy , Sarcoma/radiotherapy , Superoxide Dismutase/metabolism , Whole-Body Irradiation
3.
Phytomedicine ; 21(5): 740-4, 2014 Apr 15.
Article in English | MEDLINE | ID: mdl-24268807

ABSTRACT

To investigate Nigella sativa oil (NSO) and Thymoquinone (TQ) for their antioxidant effects on the brain tissue of rats exposed to ionizing radiation. Fifty-four male albino Wistar rats, divided into six groups, were designed as group I (normal control group) did not receive NSO, TQ or irradiation; group II (control group of TQ) received dimethyl sulfoxide and sham irradiation; group III (control group of NSO) received saline and sham irradiation; group IV (irradiation plus NSO group) received both 5 Gray of gamma irradiation to total cranium and NSO; group V (irradiation plus TQ group) received both irradiation and TQ; group VI (irradiation alone group) received irradiation plus saline. Alterations in nitric oxide (NO·) and peroxynitrite (ONOO(-)) levels, and nitric oxide synthase (NOS) enzyme activity were measured by biochemical methods in homogenized brain tissue of rats. Levels of NO· and ONOO(-), and enzyme activity of NOS in brain tissue of the rats treated with NSO or TQ were found to be lower than in received IR alone (p<0.002) Nigella sativa oil (NSO) and its active component, TQ, clearly protect brain tissue from radiation-induced nitrosative stress.


Subject(s)
Benzoquinones/therapeutic use , Brain Injuries/prevention & control , Plant Oils/therapeutic use , Radiation Injuries, Experimental/prevention & control , Reactive Nitrogen Species/adverse effects , Animals , Benzoquinones/pharmacology , Biomarkers/metabolism , Brain/metabolism , Brain Injuries/chemically induced , Brain Injuries/metabolism , Drug Evaluation, Preclinical , Male , Phytotherapy , Plant Oils/pharmacology , Radiation Injuries, Experimental/chemically induced , Radiation Injuries, Experimental/metabolism , Random Allocation , Rats, Wistar
4.
PLoS One ; 8(7): e70479, 2013.
Article in English | MEDLINE | ID: mdl-23936211

ABSTRACT

Radiation therapy in the treatment of cancer is dose limited by radiation injury in normal tissues such as the intestine and the heart. To identify the mechanistic involvement of transforming growth factor-beta 1 (TGF-ß1) in intestinal and cardiac radiation injury, we studied the influence of pharmacological induction of TGF-ß1 with xaliproden (SR 57746A) in rat models of radiation enteropathy and radiation-induced heart disease (RIHD). Because it was uncertain to what extent TGF-ß induction may enhance radiation injury in heart and intestine, animals were exposed to irradiation schedules that cause mild to moderate (acute) radiation injury. In the radiation enteropathy model, male Sprague-Dawley rats received local irradiation of a 4-cm loop of rat ileum with 7 once-daily fractions of 5.6 Gy, and intestinal injury was assessed at 2 weeks and 12 weeks after irradiation. In the RIHD model, male Sprague-Dawley rats received local heart irradiation with a single dose of 18 Gy and were followed for 6 months after irradiation. Rats were treated orally with xaliproden starting 3 days before irradiation until the end of the experiments. Treatment with xaliproden increased circulating TGF-ß1 levels by 300% and significantly induced expression of TGF-ß1 and TGF-ß1 target genes in the irradiated intestine and heart. Various radiation-induced structural changes in the intestine at 2 and 12 weeks were significantly enhanced with TGF-ß1 induction. Similarly, in the RIHD model induction of TGF-ß1 augmented radiation-induced changes in cardiac function and myocardial fibrosis. These results lend further support for the direct involvement of TGF-ß1 in biological mechanisms of radiation-induced adverse remodeling in the intestine and the heart.


Subject(s)
Heart/drug effects , Intestines/drug effects , Naphthalenes/adverse effects , Pyridines/adverse effects , Radiation Injuries, Experimental/chemically induced , Transforming Growth Factor beta1/agonists , Animals , Biomarkers/metabolism , Gamma Rays , Gene Expression/drug effects , Gene Expression/radiation effects , Heart/physiopathology , Heart/radiation effects , Inflammation/chemically induced , Inflammation/metabolism , Inflammation/pathology , Intestinal Mucosa/metabolism , Intestines/pathology , Intestines/radiation effects , Male , Radiation Dosage , Radiation Injuries, Experimental/metabolism , Radiation Injuries, Experimental/pathology , Rats , Rats, Sprague-Dawley , Transforming Growth Factor beta1/blood
5.
Pharmacol Biochem Behav ; 103(3): 487-93, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23051895

ABSTRACT

Cranial irradiation with (56)Fe, a form of space radiation, causes hippocampus-dependent cognitive changes. (56)Fe irradiation also increases reactive oxygen species (ROS) levels, which may contribute to these changes. Therefore, we investigated the effects of the antioxidant alpha lipoic acid (ALA) on cognition following sham-irradiation and irradiation. Male mice were irradiated (brain only) with (56)Fe (3 Gy) or sham-irradiated at 6-9 months of age. Half of the mice remained fed a regular chow and the other half of the mice were fed a caloric-matched diet containing ALA starting two-weeks prior to irradiation and throughout cognitive testing. Following cognitive testing, levels of 3-nitrotyrosine (3NT), a marker of oxidative protein stress, and levels of microtubule-associated protein (MAP-2), a dendritic protein important for cognition, were assessed using immunohistochemistry and confocal microscopy. ALA prevented radiation-induced impairments in spatial memory retention in the hippocampal and cortical dependent water maze probe trials following reversal learning. However, in sham-irradiated mice, ALA treatment impaired cortical-dependent novel object recognition and amygdala-dependent cued fear conditioning. There was a trend towards lower 3NT levels in irradiated mice receiving a diet containing ALA than irradiated mice receiving a regular diet. In the hippocampal dentate gyrus of mice on regular diet, irradiated mice had higher levels of MAP-2 immunoreactivity than sham-irradiated mice. Thus, ALA might have differential effects on the brain under normal physiological conditions and those involving environmental challenges such as cranial irradiation.


Subject(s)
Cranial Irradiation/psychology , Iron/toxicity , Memory Disorders/diet therapy , Memory/drug effects , Memory/radiation effects , Radiation Injuries, Experimental/diet therapy , Thioctic Acid/pharmacology , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Brain/drug effects , Brain/metabolism , Brain/radiation effects , Conditioning, Psychological/drug effects , Conditioning, Psychological/radiation effects , Cranial Irradiation/methods , Dentate Gyrus/drug effects , Dentate Gyrus/metabolism , Dentate Gyrus/radiation effects , Male , Maze Learning/drug effects , Maze Learning/radiation effects , Memory Disorders/chemically induced , Mice , Mice, Inbred C57BL , Microtubule-Associated Proteins/metabolism , Radiation Injuries, Experimental/chemically induced , Thioctic Acid/therapeutic use , Tyrosine/analogs & derivatives , Tyrosine/metabolism
6.
Acta Cir Bras ; 27(3): 223-30, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22460252

ABSTRACT

PURPOSE: To study if the pre-radiotherapy physical activity has radio-protective elements, by measuring the radio-induced activation of pro-inflammatory cytokines as interleukin-6 (il-6), transforming growth factor -ß (tgf -ß), tumor necrosis factor -α (tnf-α) and protein beta kinase ß (ikkß), through western blotting analysis. METHODS: A randomized study with 28 Wistar hannover rats, males, with a mean age of 90 days and weighing about 200 grams. The animals were divided into three groups: (GI, GII and GIII). GIII group were submitted to swimming for eight weeks (zero load, three times a week, about 30 minutes). Then, the groups (except the control group) were submitted to irradiation by cobalt therapy, single dose of 3.5 gray in the whole body. All animals were sacrificed by overdose of pentobarbital, according to the time for analysis of cytokines, and then a fragment of the lower lobe of the right lung went to western blotting analysis. RESULTS: The cytokines IKK ß, TNF-α and IL-6 induced by radiation in the lung were lower in the exercised animals. However, exercise did not alter the radiation-induced increase in tgf-ß. CONCLUSION: The results show a lower response in relation to inflammatory cytokines in the group that practiced the exercise pre-radiotherapy, showing that exercise can protect tissues from tissue damage due to irradiation.


Subject(s)
I-kappa B Kinase/metabolism , Interleukin-6/metabolism , Lung/radiation effects , Physical Conditioning, Animal/physiology , Radiation Injuries, Experimental/metabolism , Tumor Necrosis Factor-alpha/metabolism , Analysis of Variance , Animals , Blotting, Western , Cobalt Radioisotopes/administration & dosage , Lung/metabolism , Male , Radiation Injuries, Experimental/chemically induced , Radiation Injuries, Experimental/prevention & control , Random Allocation , Rats , Rats, Wistar , Time Factors
7.
Acta cir. bras ; 27(3): 223-230, Mar. 2012. ilus
Article in English | LILACS | ID: lil-617961

ABSTRACT

PURPOSE: To study if the pre-radiotherapy physical activity has radio-protective elements, by measuring the radio-induced activation of pro-inflammatory cytokines as interleukin-6 (il-6), transforming growth factor -β (tgf -β), tumor necrosis factor -α (tnf-α) and protein beta kinase β (ikkβ), through western blotting analysis. METHODS: A randomized study with 28 Wistar hannover rats, males, with a mean age of 90 days and weighing about 200 grams. The animals were divided into three groups: (GI, GII and GIII). GIII group were submitted to swimming for eight weeks (zero load, three times a week, about 30 minutes). Then, the groups (except the control group) were submitted to irradiation by cobalt therapy, single dose of 3.5 gray in the whole body. All animals were sacrificed by overdose of pentobarbital, according to the time for analysis of cytokines, and then a fragment of the lower lobe of the right lung went to western blotting analysis. RESULTS: The cytokines IKK β, TNF-α and IL-6 induced by radiation in the lung were lower in the exercised animals. However, exercise did not alter the radiation-induced increase in tgf-β. CONCLUSION: The results show a lower response in relation to inflammatory cytokines in the group that practiced the exercise pre-radiotherapy, showing that exercise can protect tissues from tissue damage due to irradiation.


OBJETIVO: Verificar se a radioterapia pré-atividade física tem elementos de rádio-proteção, medindo-se a ativação de citocinas pró-inflamatórias como a interleucina-6 (IL-6), fator transformador de crescimento - β (TGF - β), fator de necrose tumoral - α (TNF-α) e quinase de proteína beta β (IKK β), por meio da análise blotting ocidental. MÉTODOS: Um estudo randomizado empregando 28 ratos Wistar Hannover, machos, com idade média de 90 dias e pesando cerca de 200 gramas. Os animais foram divididos em três grupos: (GI, GII e GIII). Os animais do grupo GIII foram submetidos à natação durante oito semanas (carga zero, três vezes por semana, cerca de 30 minutos). Então, os grupos (exceto o grupo controle) foram submetidos à irradiação por cobalto terapia, dose única de 3,5 cinza em todo o corpo. Todos os animais foram sacrificados por overdose de pentobarbital, de acordo com o tempo de análise de citocinas, em seguida, um fragmento do lobo inferior do pulmão direito foi a análise de mata-borrão ocidental. RESULTADOS: As citocinas IKK β, TNF-α e IL-6 induzidas por radiação no pulmão foram menores nos animais que se exercitaram. No entanto, o exercício não alterou o aumento induzido pela radiação na TGF-β. CONCLUSÃO: Os resultados mostraram uma menor resposta em relação às citocinas inflamatórias no grupo que praticou o exercício físico pré-radioterapia, evidenciando que o exercício pode proteger os tecidos das lesões teciduais decorrentes da irradiação.


Subject(s)
Animals , Male , Rats , I-kappa B Kinase/metabolism , /metabolism , Lung/radiation effects , Physical Conditioning, Animal/physiology , Radiation Injuries, Experimental/metabolism , Tumor Necrosis Factor-alpha/metabolism , Analysis of Variance , Blotting, Western , Cobalt Radioisotopes/administration & dosage , Lung/metabolism , Random Allocation , Rats, Wistar , Radiation Injuries, Experimental/chemically induced , Radiation Injuries, Experimental/prevention & control , Time Factors
8.
Exp Eye Res ; 86(2): 241-50, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18078931

ABSTRACT

Previous studies have shown that melatonin treatment increases the susceptibility of retinal photoreceptors to light-induced cell death. The purpose of this study was to evaluate under various conditions the potential toxicity of dietary melatonin on retinal photoreceptors. Male and female Fischer 344 (non-pigmented) and Long-Evans (pigmented) rats were treated with daily single doses of melatonin by gavage for a period of 14 days early in the light period or early in the dark period. In another group, rats were treated 3 times per week with melatonin early in the light period, and then exposed to high intensity illumination (1000-1500 lx; HII) for 2h, and then returned to the normal cyclic lighting regime. At the end of the treatment periods, morphometric measurements of outer nuclear layer thickness (ONL; the layer containing the photoreceptor cell nuclei) were made at specific loci throughout the retinas. In male and female non-pigmented Fischer rats, melatonin administration increased the degree of photoreceptor cell death when administered during the nighttime and during the day when followed by exposure to HII. There were some modest effects of melatonin on photoreceptor cell death when administered to Fischer rats during the day or night without exposure to HII. Melatonin treatment caused increases in the degree of photoreceptor cell death when administered in the night to male pigmented Long-Evans rats, but melatonin administration during the day, either with or without exposure to HII, had little if any effect on photoreceptor cell survival. In pigmented female Long-Evans rats, melatonin administration did not appear to have significant effects on photoreceptor cell death in any treatment group. The results of this study confirm and extend previous reports that melatonin increases the susceptibility of photoreceptors to light-induced cell death in non-pigmented rats. It further suggests that during the dark period, melatonin administration alone (i.e., no HII exposure) to pigmented male rats may have a toxic effect on retinal cells. These results suggest that dietary melatonin, in combination with a brief exposure to high intensity illumination, induces cellular disruption in a small number of photoreceptors. Chronic exposure to natural or artificial light and simultaneous intake of melatonin may potentially contribute to a significant loss of photoreceptor cells in the aging retina.


Subject(s)
Melatonin/toxicity , Photoreceptor Cells, Vertebrate/drug effects , Animals , Cell Survival/drug effects , Cell Survival/radiation effects , Circadian Rhythm , Dose-Response Relationship, Drug , Female , Lighting , Male , Photic Stimulation/methods , Photoreceptor Cells, Vertebrate/pathology , Photoreceptor Cells, Vertebrate/radiation effects , Radiation Injuries, Experimental/chemically induced , Radiation Injuries, Experimental/etiology , Radiation Injuries, Experimental/pathology , Rats , Rats, Inbred F344 , Rats, Long-Evans , Sex Factors , Species Specificity
9.
Anticancer Res ; 27(4B): 2353-7, 2007.
Article in English | MEDLINE | ID: mdl-17695525

ABSTRACT

Antibodies directed against tumor necrosis factor (TNF)-alpha are clinically used for Crohn's disease, rheumatoid arthritis and psoriasis. TNF-alpha is also an important cytokine in radiotherapy because it mediates inflammatory responses in normal tissues. To study the influence of TNF-alpha inhibition on radiation toxicity, we used a well-established mouse model of kidney irradiation, where the portal also includes parts of the intestine. Mice were treated with single-fraction radiotherapy to the right kidney with doses of 8 or 10 Gy with or without the monoclonal TNF-alpha antibody infliximab injected i.v. in three doses. The kidney function was assessed by means of repeated 99mTc-dimercaptosuccinate scans during a maximum follow-up of 49 weeks. Treatment with infliximab significantly exacerbated radiation nephropathy at all time points, both in the 8 Gy and 10 Gy groups. The drug itself is not known to cause renal impairment. In the control group irradiated with 10 Gy, one mouse died from delayed radiation-induced intestinal toxicity. Skin reactions and general performance status were also similar across the groups. These data suggest that administration of infliximab concomitant to radiotherapy causes profound alterations in the development of kidney dysfunction. Importantly, other radiation-related toxicities were similar across all groups.


Subject(s)
Antibodies, Monoclonal/toxicity , Kidney Diseases/etiology , Kidney/drug effects , Kidney/radiation effects , Radiation Injuries, Experimental/etiology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Animals , Antibodies, Monoclonal/pharmacology , Female , Infliximab , Kidney Diseases/chemically induced , Mice , Mice, Inbred C3H , Radiation Injuries, Experimental/chemically induced , Tumor Necrosis Factor-alpha/immunology
10.
Int J Radiat Oncol Biol Phys ; 64(5): 1503-12, 2006 Apr 01.
Article in English | MEDLINE | ID: mdl-16503385

ABSTRACT

PURPOSE: Internal irradiation of kidneys as a consequence of radioimmunotherapy, radiation accidents, or nuclear terrorism can result in radiation nephropathy. We attempted to modify pharmacologically, the functional and morphologic changes in mouse kidneys after injection with the actinium ((225)Ac) nanogenerator, an in vivo generator of alpha- and beta-particle emitting elements. METHODS AND MATERIALS: The animals were injected with 0.35 muCi of the (225)Ac nanogenerator, which delivers a dose of 27.6 Gy to the kidneys. Then, they were randomized to receive captopril (angiotensin-converting enzyme inhibitor), L-158,809 (angiotensin II receptor-1 blocker), spironolactone (aldosterone receptor antagonist), or a placebo. RESULTS: Forty weeks after the (225)Ac injection, the placebo-control mice showed a significant increase in blood urea nitrogen (BUN) (87.6 +/- 6.9 mg/dL), dilated Bowman spaces, and tubulolysis with basement membrane thickening. Captopril treatment accentuated the functional (BUN 119.0 +/- 4.0 mg/dL; p <0.01 vs. placebo controls) and histopathologic damage. In contrast, L-158,809 offered moderate protection (BUN 66.6 +/- 3.9 mg/dL; p = 0.02 vs. placebo controls). Spironolactone treatment, however, significantly prevented the development of histopathologic and functional changes (BUN 31.2 +/- 2.5 mg/dL; p <0.001 vs. placebo controls). CONCLUSIONS: Low-dose spironolactone and, to a lesser extent, angiotensin receptor-1 blockade can offer renal protection in a mouse model of internal alpha-particle irradiation.


Subject(s)
Actinium/toxicity , Alpha Particles , Kidney/radiation effects , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/therapeutic use , Angiotensin II/antagonists & inhibitors , Angiotensin-Converting Enzyme Inhibitors/toxicity , Animals , Blood Urea Nitrogen , Captopril/toxicity , Female , Imidazoles/therapeutic use , Kidney/drug effects , Kidney/pathology , Kidney Tubules/drug effects , Kidney Tubules/pathology , Kidney Tubules/radiation effects , Mice , Mice, Inbred BALB C , Mineralocorticoid Receptor Antagonists/therapeutic use , Radiation Dosage , Radiation Injuries, Experimental/chemically induced , Radiation-Protective Agents/toxicity , Random Allocation , Spironolactone/therapeutic use , Tetrazoles/therapeutic use
11.
Acta Neurochir (Wien) ; 140(5): 495-501, 1998.
Article in English | MEDLINE | ID: mdl-9728252

ABSTRACT

In the 9L rat brain tumour model the damage to tumour and normal brain by photodynamic therapy after intratumoural photosensitizer administration (intratumoural PDT) was studied. Twenty four rats received an intratumoural injection of 4 or 40 mm3 haematoporphyrin derivative (HpD, 5 mg ml-1), followed by interstitial irradiation with 20 Joule (J) (630 nm) 5 h later. For comparison, seven rats were treated with 20 Joule 24 h after an intravenous injection of 10 mg kg-1 HpD (intravenous PDT). With the chosen PDT parameters there was no important difference between the damaged areas produced by intratumoural PDT or intravenous PDT. No selective tumour kill was observed. Even though normal brain tissue was heavily damaged, vital tumour parts were still present. Intravenous PDT caused extensive diffuse damage to small blood vessels in tumour and surrounding normal brain. Intratumoural PDT was characterised by an infiltration of polymorphonuclear cells into damaged tissue, dilatation of larger blood vessels and gross haemorrhage. These results suggest an immediate vascular shutdown in the intravenous approach, while in the intratumoural approach the vasculature remained patent initially. Because of the severe side effects observed, the use of HpD seems not advisable for intratumoural PDT of brain tumours.


Subject(s)
Brain Neoplasms/drug therapy , Disease Models, Animal , Gliosarcoma/drug therapy , Hematoporphyrin Derivative , Hematoporphyrin Photoradiation , Photosensitizing Agents , Animals , Brachytherapy/adverse effects , Brachytherapy/methods , Brain Injuries/etiology , Brain Injuries/pathology , Brain Neoplasms/pathology , Gliosarcoma/pathology , Hematoporphyrin Derivative/administration & dosage , Hematoporphyrin Derivative/adverse effects , Hematoporphyrin Photoradiation/adverse effects , Hematoporphyrin Photoradiation/methods , Injections, Intralesional , Injections, Intravenous , Male , Necrosis , Neoplasm Invasiveness , Photosensitizing Agents/administration & dosage , Photosensitizing Agents/adverse effects , Radiation Injuries, Experimental/chemically induced , Radiation Injuries, Experimental/pathology , Rats , Rats, Inbred Strains , Tumor Cells, Cultured/transplantation
12.
Br J Radiol ; 65(770): 152-6, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1540807

ABSTRACT

An experimental model in the rat has been used to assess the possible enhancement of damage to the spinal cord when radiation is given in the presence of methotrexate (MTX). The dose of MTX used, 4 mg/kg, was the maximum dose that could be given to the rat, when administered into the cerebral spinal fluid circulation, without risk of serious neurological effects. Lengths of 4, 8 and 16 mm of the cervical spine were irradiated with single doses of X rays. For animals that developed paralysis within 30 weeks, caused predominantly by the presence of white matter necrosis, there was no evidence to indicate that MTX enhanced the radiation response of the rat spinal cord, at least at a more clinically relevant level of effect i.e. a low incidence of paralysis. However, for the doses associated with the 50% level of effect (ED50) to an 8 mm long field a significant (p less than 0.005) enhancement of the response was seen, suggesting a dose modification factor of 1.19 +/- 0.07. This was interpreted in terms of an hypothesis to explain the well documented volume effect for very small fields in the rat spinal cord which is based on the migration of viable cells in the periphery of the irradiated site. The apparent smaller effect seen when only 4 mm of the spine was irradiated might be related to the nature of the lesion induced at doses required to produce paralysis in these small fields; the lesions were not restricted to white matter but were more severe and also involved the grey matter and nerve roots after a slightly shorter latent period.


Subject(s)
Methotrexate/adverse effects , Paralysis/chemically induced , Radiation Injuries, Experimental/chemically induced , Spinal Cord/radiation effects , Animals , Dose-Response Relationship, Drug , Female , Rats , Rats, Inbred Strains
13.
Pediatr Hematol Oncol ; 8(2): 187-92, 1991.
Article in English | MEDLINE | ID: mdl-1863544

ABSTRACT

No mention of dactinomycin potentiation of pulmonary radiation was found in a review of the literature of the past 12 years. Before that, this complication was well described and investigators had calculated that dactinomycin increased the toxic effect of lung radiation by a factor of 1.3 and reduced the radiation tolerance of the lung by at least 20%. An example of such a toxic effect is described in the treatment of a 7-year-old girl with lung metastases from Ewing's sarcoma. The chemotherapy protocol followed contained cyclophosphamide, vincristine, dactinomycin, adriamycin, cisplatinum, VP16, and radiotherapy. The treatment was associated with fatal pulmonary fibrosis following the reintroduction of dactinomycin after radiotherapy. Our experience suggests that there is clinical significance to this complication in sarcoma therapy when dactinomycin-containing protocols are used with radiation in the treatment of pulmonary metastases.


Subject(s)
Dactinomycin/adverse effects , Femoral Neoplasms/drug therapy , Lung Neoplasms/metabolism , Pulmonary Fibrosis/etiology , Radiotherapy/adverse effects , Sarcoma, Ewing/metabolism , Animals , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Child , Cisplatin/administration & dosage , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Dactinomycin/administration & dosage , Dactinomycin/toxicity , Doxorubicin/administration & dosage , Etoposide/administration & dosage , Female , Humans , Lung/metabolism , Lung/radiation effects , Lung Neoplasms/drug therapy , Lung Neoplasms/radiotherapy , Mice , Radiation Injuries, Experimental/chemically induced , Radiation Tolerance/drug effects , Sarcoma, Ewing/drug therapy , Sarcoma, Ewing/radiotherapy , Vincristine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...